Artificial intelligence is often framed as the great equalizer in modern medicine, a tool capable of stripping away human prejudice to provide objective, data-driven care. From predicting cardiac arrest hours before it happens to identifying malignant melanomas with superhuman precision, the promise of AI is a healthcare system that is more efficient, more accurate, and more accessible.
However, as a physician and journalist, I have seen that technology is rarely a neutral actor. AI does not exist in a vacuum; it is trained on data generated by a world already fraught with systemic inequality. When we feed biased data into a machine, the machine does not erase the bias—it automates it, scaling disparities at a speed and volume that human clinicians could never achieve on their own.
The growing utilize of AI in healthcare racial disparities is no longer a theoretical risk discussed in ethics seminars; it is a documented reality in clinics and hospitals. When algorithms are designed without a rigorous commitment to equity, they risk transforming historical prejudices into “objective” clinical mandates, potentially denying life-saving interventions to the populations that need them most.
Understanding this intersection of technology and sociology is critical for patients and providers alike. To ensure that medical innovation serves everyone, we must move beyond the excitement of the “black box” and demand transparency in how these tools are built, tested, and deployed.
The Data Mirror: How Bias Enters the Algorithm
To understand how AI perpetuates disparity, one must first understand the “training set.” Machine learning models learn to recognize patterns by analyzing massive datasets of previous medical outcomes. If the data used to train the AI is skewed, the resulting tool will be skewed. This is often referred to as “garbage in, garbage out,” but in medicine, the “garbage” is often a reflection of systemic racism and socio-economic barriers.
For example, many AI models used in dermatology are trained on datasets primarily composed of images of fair-skinned patients. When these tools are applied to patients with darker skin tones, their accuracy drops significantly. This creates a dangerous gap in care: a tool that can save a life by detecting early-stage skin cancer in a white patient may fail to recognize the same pathology in a Black or Hispanic patient, leading to delayed diagnoses and worse outcomes.
This is not merely a technical glitch but a systemic failure. For decades, medical textbooks and research studies have underrepresented non-white populations. When AI developers scrape this existing medical literature to build their models, they are essentially digitizing a century of exclusion. The algorithm “learns” that the standard for “healthy” or “diseased” is based on a specific demographic, treating all other variations as outliers or noise.
The Danger of Proxy Variables: When Spending Equals Health
One of the most insidious forms of AI bias occurs not through a lack of data, but through the use of “proxy variables.” A proxy variable is a piece of data used to stand in for something else that is harder to measure. In healthcare, a common proxy for “health need” has been “healthcare spending.” The logic seems simple: patients who cost the system more money must be the sickest and therefore require the most resources.
This logic fails catastrophically when applied to populations with unequal access to care. In a landmark study published in Science, researchers found that a widely used health-risk algorithm was significantly less likely to refer Black patients for complex care management than white patients with the same level of chronic illness. The reason was the proxy: because of systemic barriers and lower historical spending on Black patients, the AI concluded they were “healthier” than white patients who had more access to expensive treatments.
The result was a machine-learning tool that effectively penalized patients for being victims of a biased healthcare system. By using cost as a proxy for need, the AI didn’t just reflect the disparity—it reinforced it, ensuring that those who had historically received less care continued to receive less, all under the guise of an “objective” algorithmic score.
Impact Across Clinical Domains
The implications of algorithmic bias extend across nearly every specialty in medicine, from triage and diagnostics to psychiatric care and resource allocation.
Diagnostics and Imaging
In radiology and pathology, AI is used to flag anomalies in X-rays and MRIs. However, if the training data lacks diversity, the AI may struggle to account for anatomical variations across different ethnic groups. This can lead to higher rates of false negatives in minority populations, meaning diseases are caught later, when they are harder to treat.
Psychiatric Care and Treatment Regimens
The risk is equally high in mental health. AI tools used to suggest treatment regimens or predict patient risk can be influenced by biased clinical notes. If physicians have historically documented patients of color as “non-compliant” or “aggressive” more frequently than white patients—regardless of actual behavior—the AI will learn these associations. This can lead to the recommendation of more restrictive treatments or the denial of certain therapies based on a learned racial stereotype rather than clinical necessity.
Triage and Resource Allocation
During crises, such as the COVID-19 pandemic, AI-driven triage tools were explored to help hospitals decide who should receive limited resources, such as ventilators. If these tools rely on “quality-adjusted life years” (QALYs) or other metrics that do not account for the systemic health burdens placed on marginalized communities, they risk systematically deprioritizing minority patients during medical emergencies.
Toward a Framework of Algorithmic Justice
Solving the problem of AI bias requires more than just “more data.” It requires a fundamental shift in how medical AI is governed. We cannot simply add a few thousand diverse images to a dataset and call the problem solved; we must address the structural ways in which bias is encoded.
First, there must be a mandate for dataset transparency. Developers should be required to disclose the demographic makeup of their training sets. If a tool is trained on a population that is 90% Caucasian, it should be clearly labeled as such, and clinicians should be cautioned about its efficacy across different racial and ethnic groups.
Second, we need a move toward equity-focused validation. Rather than reporting a single accuracy percentage for a tool, developers should be required to report “disaggregated” data. This means showing how the AI performs for Black patients, Hispanic patients, Asian patients, and white patients separately. If the accuracy gap is too wide, the tool should not be cleared for clinical use.
Regulatory bodies are beginning to respond. The EU AI Act, which entered into force in 2024, classifies many healthcare AI applications as “high-risk,” subjecting them to stricter requirements regarding data quality, documentation, and human oversight. In the United States, the FDA has released a framework for the “Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Device Software Action Plan,” aiming to create a more adaptive regulatory pathway that monitors AI performance in real-time after it hits the market.
Key Takeaways for Patients and Providers
- AI is not neutral: Algorithms learn from historical data, which often contains systemic biases regarding race, ethnicity, and gender.
- The “Proxy” Problem: Using financial data (like healthcare spending) as a substitute for health need can lead to the systematic under-treatment of marginalized groups.
- Representation Matters: AI tools trained on limited demographics (e.g., primarily light-skinned patients in dermatology) are less accurate for diverse populations.
- Demand Transparency: Patients and providers should ask whether a tool has been validated across diverse racial and ethnic groups before relying on its output.
- Regulatory Shift: Novel laws, like the EU AI Act, are starting to categorize healthcare AI as “high-risk” to ensure better oversight.
The Role of the Human Clinician
The goal of AI should not be to replace the physician, but to augment them. The most dangerous scenario is “automation bias,” where a clinician trusts the AI’s output so implicitly that they ignore their own clinical judgment or the patient’s reported symptoms.
As a physician, I believe the antidote to algorithmic bias is critical skepticism. Clinicians must be trained to view AI as a “second opinion” rather than an absolute truth. When an AI suggests a diagnosis or a treatment plan, the provider must ask: “Does this align with the patient’s actual presentation, or is the AI reflecting a pattern from a dataset that doesn’t look like this patient?”
True health equity in the age of AI will not come from a better line of code, but from a combination of inclusive data, rigorous regulation, and a medical workforce that is trained to challenge the machine.
What Happens Next
The conversation around AI and health equity is moving toward “algorithmic auditing.” We are seeing the emergence of third-party organizations that specialize in stress-testing medical AI for bias before it is deployed in hospitals. This “audit culture” will be essential in moving from reactive corrections to proactive prevention.
The next major checkpoint for the industry will be the full implementation of the EU AI Act’s requirements for high-risk systems, which will set a global benchmark for how medical AI must be documented and monitored. The World Health Organization (WHO) continues to develop guidance on the ethics and governance of large multi-modal models in healthcare, focusing specifically on preventing the exacerbation of global health disparities.
As we integrate these powerful tools into our clinics, we must remember that the primary goal of medicine is to heal. If our tools only heal some while ignoring others, they are not innovations—they are liabilities.
Do you believe AI will eventually eliminate human bias in medicine, or will it only make it harder to detect? We invite you to share your thoughts in the comments below or share this article with your healthcare providers to start the conversation.